EUVIMEDEUVIMED entdecken
Crossref

Near-infrared photoimmunotherapy and anti-cancer immunity

Kohei Nakajima iD, Mikako Ogawa

International Immunology · 14.02.2024 · 36 (2) · 57-64

DOI: 10.1093/intimm/dxad042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunology, online erschienen am 16.10.2023. Verfasst von Kohei Nakajima und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Bioanalysis and Molecular Imaging, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Hokkaido 060-0812, Japan. Hauptthemen laut MEDLINE: Phototherapy, Immunoconjugates. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 85 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Hokkaido University, Takeda Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The activation of the anti-cancer immune system is an important strategy to control cancer. A new form of cancer phototherapy, near-infrared photoimmunotherapy (NIR-PIT), was approved for clinical use in 2020 and uses IRDye® 700DX (IR700)-conjugated antibodies and NIR light. After irradiation with NIR light, the antibody–IR700 conjugate forms water-insoluble aggregations on the plasma membrane of target cells. This aggregation causes lethal damage to the plasma membrane, and effectively leads to immunogenic cell death (ICD). Subsequently, ICD activates anti-cancer immune cells such as dendritic cells and cytotoxic T cells. Combination therapy with immune-checkpoint blockade has synergistically improved the anti-cancer effects of NIR-PIT. Additionally, NIR-PIT can eliminate immunosuppressive immune cells in light-irradiated tumors by using specific antibodies against regulatory T cells and myeloid-derived suppressor cells. In addition to cancer-cell-targeted NIR-PIT, such immune-cell-targeted NIR-PIT has shown promising results by activating the anti-cancer immune system. Furthermore, NIR-PIT can be used to manipulate the tumor microenvironment by eliminating only targeted cells in the tumor, and thus it also can be used to gain insight into immunity in basic research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhototherapyImmunoconjugatesCell Line, TumorImmunotherapy

Stichwörter der Autor:innen

IR700NIR-PITantibodyimmunogenic cell deathphototherapy

Substanzen

Immunoconjugates

Autor:innen und Institutionen

  • Laboratory of Bioanalysis and Molecular Imaging, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Hokkaido 060-0812, Japan.

ORCID-Profile: Kohei Nakajima

Förderung

  • Japan Society for the Promotion of Science
  • Hokkaido University
  • Takeda Science Foundation

Zitieren

APA

Nakajima, K., & Ogawa, M. (2024). Near-infrared photoimmunotherapy and anti-cancer immunity. International Immunology, 36(2), 57-64. https://doi.org/10.1093/intimm/dxad042

Vancouver

Nakajima K, Ogawa M. Near-infrared photoimmunotherapy and anti-cancer immunity. International Immunology. 2024;36(2):57-64. doi:10.1093/intimm/dxad042

BibTeX
@article{Nakajima2024,
  author = {Nakajima, Kohei and Ogawa, Mikako},
  title = {Near-infrared photoimmunotherapy and anti-cancer immunity},
  journal = {International Immunology},
  year = {2024},
  volume = {36},
  number = {2},
  pages = {57--64},
  doi = {10.1093/intimm/dxad042}
}
Kostenlos starten →